Cart
sales@molnova.com
Dimethyl biphenyl-44'-dicarboxylate
CAS No. 792-74-5
Dimethyl biphenyl-44'-dicarboxylate( Biphenyl dimethyl dicarboxylate )
Catalog No. M20608 CAS No. 792-74-5
Dimethyl biphenyl-44'-dicarboxylate is a planar biphenyldicarboxylic acid ester used as a hepatoprotectant in the treatment of chronic hepatitis.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | 27 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameDimethyl biphenyl-44'-dicarboxylate
-
NoteResearch use only, not for human use.
-
Brief DescriptionDimethyl biphenyl-44'-dicarboxylate is a planar biphenyldicarboxylic acid ester used as a hepatoprotectant in the treatment of chronic hepatitis.
-
DescriptionDimethyl biphenyl-44'-dicarboxylate is a planar biphenyldicarboxylic acid ester used as a hepatoprotectant in the treatment of chronic hepatitis.
-
In Vitro——
-
In Vivo——
-
SynonymsBiphenyl dimethyl dicarboxylate
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number792-74-5
-
Formula Weight270.28
-
Molecular FormulaC16H14O4
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 2 mg/mL (7.40 mMultr)
-
SMILESCOC(=O)c1ccc(cc1)-c1ccc(cc1)C(=O)OC
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Fu T Liu G . Protective effects of biphenyl dimethyl dicarboxylate on damage in isolated rat hepatocytes induced by carbon tetrachloride and D-galactosamine[J]. Zhonghua Yi Xue Za Zhi 1990 70(4):201-4 16.
molnova catalog
related products
-
Kemptide Phospho-Ser...
Kemptide (Phospho-Ser5) is a phosphoreceptor peptide that is a specific substrate for camp-dependent protein kinase (PKA).
-
MAGE-3 Antigen (168-...
MAGE-3 peptide (MAGE-3 168-176, human) is a peptide encoded by human MAGE-3 gene, which is expressed in tumor cells, presented by HLA and recognized by cytolytic T lymphocytes (CTL) as tumor antigen.
-
EZM0414 TFA
EZM0414 TFA (SETD2-IN-1 TFA) is a SETD2 inhibitor with anticancer and antiproliferative effects for the study of leukemia and immune dysfunction.
